Key points are not available for this paper at this time.
Accurate risk stratification of nonischemic dilated cardiomyopathy (NIDCM) remains challenging.
Eichhorn et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: